CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50 112 subjects

Polymorphisms in the promoter region of the CASP8 gene are not associated with non-Hodgkin’s lymphoma in Chinese patients

(2011) Mei-Sheng Xiao et al.   ANNALS OF HEMATOLOGY

Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer

(2011) Emmanouil Liamarkopoulos et al.   Gastric Cancer

Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer

(2011) Xiangdong Ma et al.   GYNECOLOGIC ONCOLOGY

Polymorphisms of Caspase 8 and Caspase 9 gene and colorectal cancer susceptibility and prognosis

(2011) George E. Theodoropoulos et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer

(2011) Koushik Chatterjee et al.   JOURNAL OF MEDICAL VIROLOGY

CASP8 −652 6N del and CASP8 IVS12-19G>A gene polymorphisms and susceptibility/prognosis of ESCC: A case control study in northern Indian population

(2011) Meenakshi Umar et al.   JOURNAL OF SURGICAL ONCOLOGY

Gallbladder Cancer Predisposition: A Multigenic Approach to DNA-Repair, Apoptotic and Inflammatory Pathway Genes

(2011) Kshitij Srivastava et al.   PLoS One

The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers

(2010) Irene Catucci et al.   BREAST CANCER RESEARCH AND TREATMENT

Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

(2010) C. Engel et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The Six-Nucleotide Deletion/Insertion Variant in the CASP8 Promoter Region Is Inversely Associated with Risk of Squamous Cell Carcinoma of the Head and Neck

(2010) C. Li et al.   Cancer Prevention Research

CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies

(2010) Ming Yin et al.   CARCINOGENESIS

Caspase 9 and Caspase 8 Gene Polymorphisms and Susceptibility to Bladder Cancer in North Indian Population

(2009) Ruchika Gangwar et al.   ANNALS OF SURGICAL ONCOLOGY

CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers

(2009) Sarai Palanca Suela et al.   BREAST CANCER RESEARCH AND TREATMENT

A Six-Nucleotide Insertion-Deletion Polymorphism in the CASP8 Promoter Associated with Risk and Progression of Bladder Cancer

(2009) M. Wang et al.   CLINICAL CANCER RESEARCH

Predictors of Competing Mortality in Advanced Head and Neck Cancer

(2009) Loren K. Mell et al.   JOURNAL OF CLINICAL ONCOLOGY

Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases

(2008) Giovanna De Vecchi et al.   BREAST CANCER RESEARCH AND TREATMENT

CASP8 variants D302H and −652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population

(2008) A M Pittman et al.   BRITISH JOURNAL OF CANCER

The Common D302H Variant of CASP8 Is Associated with Risk of Glioma

(2008) L. Bethke et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

CASP8 D302H and meningioma risk: An analysis of five case-control series

(2008) Lara Bethke et al.   CANCER LETTERS

Functional Variants in Cell Death Pathway Genes and Risk of Pancreatic Cancer

(2008) M. Yang et al.   CLINICAL CANCER RESEARCH

Genetic variants and haplotypes of thecaspase-8andcaspase-10genes contribute to susceptibility to cutaneous melanoma

(2008) Chunying Li et al.   HUMAN MUTATION

A promoter polymorphism in the CASP8 gene is not associated with cancer risk

(2008) Christopher A Haiman et al.   NATURE GENETICS